Luteinizing hormone-releasing hormone antagonists

review OA: closed public-domain-us
View on PubMed View at publisher
AI-generated summary by qwen3.7-flash, 2026-08-30

This review examines relevant luteinizing hormone-releasing hormone antagonists, their therapeutic applications in endometriosis and other conditions, recent patents, drug formulations, and ongoing development of peptidic and non-peptidic compounds.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

BACKGROUND: Luteinizing hormone-releasing hormone (LH-RH) plays a central role in the vertebrate reproduction by regulating gonadal activity. Based on its binding to pituitary LH-RH receptors, as well as to LH-RH receptors expressed on cancer cells, LH-RH agonists and antagonists have been developed for different therapeutic applications. OBJECTIVE/METHOD: Here we give an overview of the most relevant LH-RH antagonists and their therapeutic applications. Recently patented compounds as well as drug formulations and dosage are presented. CONCLUSION: LH-RH antagonists have found clinical applications in in vitro fertilization, benign prostatic hyperplasia, endometriosis and in the treatment of hormone-dependent tumors. Work in progress is focused on further development of both peptidic and orally active non-peptidic LH-RH antagonists.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Fertilization in Vitro Gonadotropin-Releasing Hormone Neoplasms Animals Antineoplastic Agents Antineoplastic Agents Drug Design Endometriosis Endometriosis Endometriosis Female Fertilization in Vitro Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Humans Male Neoplasms Neoplasms Patents as Topic

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-09-14T06:17:53.580500+00:00
pubmed
last seen: 2026-05-13T22:13:53.633898+00:00
unpaywall
last seen: 2026-09-14T06:35:54.356137+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine